0001209191-23-026488.txt : 20230502 0001209191-23-026488.hdr.sgml : 20230502 20230502162252 ACCESSION NUMBER: 0001209191-23-026488 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230217 FILED AS OF DATE: 20230502 DATE AS OF CHANGE: 20230502 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Yu Tony CENTRAL INDEX KEY: 0001937482 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-41599 FILM NUMBER: 23879404 MAIL ADDRESS: STREET 1: C/O GENELUX CORPORATION STREET 2: 2625 TOWNSGATE ROAD, SUITE 230 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91361 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENELUX CORP CENTRAL INDEX KEY: 0001231457 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1177 IDAHO STREET CITY: REDLANDS STATE: CA ZIP: 92374 BUSINESS PHONE: 858-483-0024 MAIL ADDRESS: STREET 1: 1177 IDAHO STREET CITY: REDLANDS STATE: CA ZIP: 92374 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-02-17 0 0001231457 GENELUX CORP GNLX 0001937482 Yu Tony C/O GENELUX CORPORATION 2625 TOWNSGATE ROAD, SUITE 230 WESTLAKE VILLAGE CA 91361 0 1 0 0 VP, Clinical Trial Operations 0 Common Stock 2023-02-17 4 A 0 9000 0.00 A 159000 D Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of common stock upon vesting. The RSUs will be fully vested on July 25, 2023. /s/ Thomas Zindrick, Attorney-in-Fact 2023-05-02